New research from the Trudeau Institute reveals a negative feedback loop regulating immune response to bacteria, preventing tissue damage while controlling bacterial growth. The study's findings have potential applications in improving prevention and treatment strategies for bacterial infections.
The Trudeau Institute has received a National Institutes of Health grant to study new treatments for bacterial infections. The institute's lab will investigate the effectiveness of Aronora's therapeutic approach on various types of bacterial infections, building on earlier studies that showed promise in mice.
A study by the Trudeau Institute has identified key mechanisms in controlling gamma-herpesvirus infections and their implications for treating and preventing cancer. Researchers found that immune responses differ between initial active phase and long-term latent infection phases.
Researchers at the Trudeau Institute have discovered a new properties of a potential vaccine adjuvant that suggests it could be useful for enhancing protection against a number of different infections. The discovery provides a promising lead for developing a new class of vaccines.
Researchers at Trudeau Institute found a link between the formation of new lymphoid tissue in the lungs and protection from tuberculosis. The study, published in The Journal of Immunology, may lead to improved vaccines and therapies for fighting deadly disease.
The Trudeau Institute has made a breakthrough in treating Listeria infections by identifying a key role for blood-clotting proteins in immune defense. The study suggests that FXI-targeted therapeutics may be useful for treating severe infections caused by Listeria and other sepsis-causing bacteria.
Researchers at the Trudeau Institute have discovered that FluMist elicits protection by inducing a very early non-specific immune response in the lungs, which is protective against both matching and non-matching influenza strains. This response also limits lung inflammation and reduces susceptibility to secondary bacterial infections.
Researchers at the Trudeau Institute have identified a previously unknown link between the migration of white blood cells to infected tissues and their ability to survive as long-lived memory cells. This discovery aims to improve vaccine efficacy, particularly for the elderly population.
Researchers found that mice lacking fibrin showed dramatically decreased survival and increased bacterial loads during gram-negative sepsis. Fibrin helps protect bodies during infection, and its regulation may hold the key to preventing organ failure in sepsis patients.
A new discovery has been made in the fight against plague and bacterial pneumonias by researchers at the Trudeau Institute. They have identified a single component of the plague causing bacterium that can be used as a vaccine, offering a potential safer alternative to existing vaccines.
Scientists have made a breakthrough in developing a vaccine to protect against plague and bacterial pneumonias. The new discovery involves the stimulation of Th1-17 cells, which provide partial protection against pneumonic plague.
Researchers at the Trudeau Institute and St. Jude Children's Research Hospital are studying white blood cell migration in response to viral infections, which could lead to improved vaccine strategies. The study has major implications for developing vaccines that promote immunity to respiratory infections.
Researchers discover that CD4+ T cells release interleukin-21, instructing B cells to produce antibodies targeting helminth-derived products. This signaling pathway is specific to worm infections and may hold key to treating diseases like asthma and allergies.
A new vaccine development aims to protect humans from pneumonic plague by combining antibodies with cytokines, addressing concerns about the effectiveness of existing treatments. The Trudeau Institute is leading this research in collaboration with the US and UK militaries.
Scientists at the Trudeau Institute have identified two crucial signals that enable virus-fighting T cells to migrate to the lungs, where they can fight future infections. This breakthrough could lead to the development of vaccines designed to promote respiratory immunity.
Researchers at the Trudeau Institute discovered that cytokines can influence immune responses to subsequent infections and vaccination procedures. This knowledge provides a potential explanation for why chronic infections can alter immune responses to vaccines. Needle vaccinations may be more effective in regions where people are alrea...
A new study from Trudeau Institute reveals that older animals' immune cells live longer but acquire functional defects. This research may provide new targets to boost immune system function in older individuals, improving vaccine efficacy.
Researchers at the Trudeau Institute have identified a single protein, omega-1, secreted from schistosome eggs that induces a specific immune response. This discovery may lead to new treatments and therapies for schistosomiasis, one of the most important neglected tropical diseases.
Researchers have discovered a transient protective effect of herpesvirus infections in mice, suggesting possible benefits against bacterial pathogens. The findings, confirmed by Dr. Marcia Blackman's team, contradict previous suggestions that vaccinated individuals may experience unintended negative consequences.
Researchers may develop new treatments for diseases like multiple sclerosis, rheumatoid arthritis, and sepsis by understanding the role of fibrin in blood coagulation. The NIH grant will support a four-year study to identify how cytokines regulate fibrin levels.
Researchers at the Trudeau Institute have made a new discovery about how white blood cells are navigated to the lung airways during an influenza infection. The findings suggest that specific types of white blood cells can recognize chemical messages produced by infected lungs, allowing them to move into tissues and attack the virus.